Germany
Japan
United Kingdom
China
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Research Areas
View as table DownloadUSD 390.00
2 Weeks
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HCA2, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
CD13 (ANPEP) mouse monoclonal antibody, clone WM15, Purified
| Applications | ELISA, FC, FN, IHC, IP |
| Reactivities | Human, Primate |
USD 428.00
In Stock
HLA Class I ABC mouse monoclonal antibody, clone W6/32, Purified
| Applications | ELISA, FC, IF, IHC, IP |
| Reactivities | Bovine, Feline, Human, Monkey, Primate |
HLA Class I ABC mouse monoclonal antibody, clone W6/32, Low Endotoxin
| Applications | ELISA, FC, FN, IF, IHC, IP |
| Reactivities | Bovine, Chimpanzee, Feline, Human, Macaque, Monkey, Primate, Baboon |
USD 440.00
2 Weeks
USD 440.00
2 Weeks
IL1 Receptor I (IL1R1) (Extracell. Dom.) mouse monoclonal antibody, clone 40101, Purified
| Applications | ELISA, IHC, R |
| Reactivities | Human |
USD 745.00
5 Days
Tumor necrosis factor (TNF-alpha) rat monoclonal antibody, clone MP6-XT22, Low Endotoxin
| Applications | ELISA, FC, FN, IHC |
| Reactivities | Mouse, Rat |
Feline Coronavirus mouse monoclonal antibody, clone FIPV3-70, Purified
| Applications | ELISA, FC, IF, IHC, WB |
IL6 mouse monoclonal antibody, clone B-E8, Azide Free
| Applications | ELISA, FC, FN |
| Reactivities | Human |
CD20 (MS4A1) mouse monoclonal antibody, clone NKI-B20/1, Purified
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human |
CD56 (NCAM1) mouse monoclonal antibody, clone ERIC-1, Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Porcine |
CD61 (ITGB3) mouse monoclonal antibody, clone BV4, Purified
| Applications | ELISA, FN, IHC, IP, WB |
| Reactivities | Bovine, Human |
Il1r1 rat monoclonal antibody, clone REG21, Purified
| Applications | ELISA, FN, IP, WB |
| Reactivities | Mouse |
Tnfrsf1b rat monoclonal antibody, clone HM102, Aff - Purified
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Mouse |
WNT5A mouse monoclonal antibody, clone 6F2, Ascites
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human |
Temporarily out of stock
TLR2 mouse monoclonal antibody, clone TL2.3, Purified
| Applications | ELISA, FC, FN, IF, IHC, WB |
| Reactivities | Canine, Human |
TNFRSF1B mouse monoclonal antibody, clone MR2-1, Purified
| Applications | ELISA, FC, FN, IHC, IP, WB |
| Reactivities | Human, Monkey |
Tnfrsf1b rat monoclonal antibody, clone HM102, FITC
| Applications | ELISA, FC, FN, IHC, IP, WB |
| Reactivities | Mouse |
| Conjugation | FITC |
Tnfrsf1b rat monoclonal antibody, clone HM102, Purified
| Applications | ELISA, FC, FN, IHC, IP, WB |
| Reactivities | Mouse |
CD8A mouse monoclonal antibody, clone C8/468, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
MUC2 mouse monoclonal antibody, clone CCP58, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
MUC2 mouse monoclonal antibody, clone CCP58, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
IL4 mouse monoclonal antibody, Azide Free
| Applications | ELISA, FN, IHC |
| Reactivities | Human |
CCL3 mouse monoclonal antibody, Azide Free
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Human |
CD5 mouse monoclonal antibody, clone MEM-32, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
HLAG (HLA-G) (C-term) mouse monoclonal antibody, clone 5A6G7, Purified
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human |
HLAG (HLA-G) mouse monoclonal antibody, clone 01G, Purified
| Applications | ELISA, FC, IF, IHC, IP |
| Reactivities | Human |
Galectin 3 (LGALS3) mouse monoclonal antibody, clone B2C10, Purified
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Human, Mouse |
TLR1 mouse monoclonal antibody, clone GD2.F4, Purified
| Applications | ELISA, FC, FN, IF, IHC |
| Reactivities | Human |
TNF alpha (TNF) mouse monoclonal antibody, clone 4H31, Purified
| Applications | ELISA, FN, IHC, IP, WB |
| Reactivities | Human, Monkey |
Active filters
Applications
- ELISA
Clonalities
- Monoclonal
Filter by
Target Symbol
- IL6 (110)
- IL1RL1 (102)
- TNF (10)
- PDCD1 (9)
- MAPK8 (8)
- CD4 (7)
- CD5 (6)
- CD274 (4)
- CD33 (4)
- IL2RA (4)
- IL3RA (4)
- TNFRSF8 (4)
- IL10 (3)
- TYRO3 (3)
- CD1A (2)
- CD46 (2)
- CD74 (2)
- ESR1 (2)
- IL18 (2)
- IL2 (2)
- IL6R (2)
- IL6RA (2)
- ITGA2B (2)
- ITGAX (2)
- NCAM1 (2)
- WNT3A (2)
- CALR (1)
- CD14 (1)
- CXCL8 (1)
- HLA-G (1)
- IL12B (1)
- IL1R1 (1)
- IL4 (1)
- IL6ST (1)
- MAPK9 (1)
- MS4A1 (1)
- SOS1 (1)
Reactivities
Antibody Hosts
Isotypes
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (262)
- Secreted Protein (219)
- Transmembrane (135)
- ES Cell Differentiation/IPS (13)
- Protein Kinase (12)
- Adult stem cells (3)
- Transcription Factors (3)
- Cancer stem cells (2)
- Induced pluripotent stem cells (2)
- Nuclear Hormone Receptor (2)
- Stem cell relevant signaling - Wnt Signaling pathway (2)
- Embryonic stem cells (1)
Pathways
- Hematopoietic cell lineage (124)
- Pathways in cancer (122)
- Toll-like receptor signaling pathway (122)
- NOD-like receptor signaling pathway (120)
- Cytokine-cytokine receptor interaction (116)
- Jak-STAT signaling pathway (114)
- Graft-versus-host disease (111)
- Hypertrophic cardiomyopathy (HCM) (110)
- Cytosolic DNA-sensing pathway (109)
- Prion diseases (109)
- Cell adhesion molecules (CAMs) (14)
- T cell receptor signaling pathway (14)
- MAPK signaling pathway (13)
- Fc epsilon RI signaling pathway (12)
- RIG-I-like receptor signaling pathway (12)
- Wnt signaling pathway (11)
- Adipocytokine signaling pathway (10)
- Colorectal cancer (10)
- Epithelial cell signaling in Helicobacter pylori infection (10)
- ErbB signaling pathway (10)
- Focal adhesion (10)
- GnRH signaling pathway (10)
- Insulin signaling pathway (10)
- Neurotrophin signaling pathway (10)
- Type II diabetes mellitus (10)
- Pancreatic cancer (9)
- Progesterone-mediated oocyte maturation (9)
- Allograft rejection (5)
- Asthma (3)
- Autoimmune thyroid disease (3)
- Natural killer cell mediated cytotoxicity (3)
- Type I diabetes mellitus (3)
- Apoptosis (2)
- Basal cell carcinoma (2)
- Chemokine signaling pathway (2)
- Complement and coagulation cascades (2)
- Hedgehog signaling pathway (2)
- Melanogenesis (2)
- Regulation of actin cytoskeleton (2)
- Systemic lupus erythematosus (2)
- Acute myeloid leukemia (1)
- Alzheimer's disease (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Antigen processing and presentation (1)
- B cell receptor signaling pathway (1)
- Bladder cancer (1)
- Chronic myeloid leukemia (1)
- Dilated cardiomyopathy (1)
- Dorso-ventral axis formation (1)
- Endocytosis (1)
- Endometrial cancer (1)
- Gap junction (1)
- Glioma (1)
- Non-small cell lung cancer (1)
- Pathogenic Escherichia coli infection (1)
- Prostate cancer (1)
- Renal cell carcinoma (1)
- TGF-beta signaling pathway (1)
- Viral myocarditis (1)